tetraethylammonium has been researched along with Rheumatic Diseases in 2 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Rheumatic Diseases: Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MORELLI, A | 1 |
| MAZZELLA di BOSCO, M | 1 |
| FEROND, M | 1 |
2 other studies available for tetraethylammonium and Rheumatic Diseases
| Article | Year |
|---|---|
[Tetraethylammonium bromide associated with the Lewin and Wassen therapy in rheumatic diseases].
Topics: Ammonia; Ammonium Compounds; Arthritis; Arthritis, Rheumatoid; Bromides; Bromine; Quaternary Ammoniu | 1950 |
[Tetraethylammonium therapy of pain in the shoulder].
Topics: Ammonia; Ammonium Compounds; Pain; Quaternary Ammonium Compounds; Rheumatic Diseases; Shoulder; Tetr | 1950 |